Browse Items (2 total)

Objective: To describe the serological and clinical profile of antibody positive autoimmune gastrointestinal dysmotility patients receiving IVIg

Objective: To identify the frequency of insurance related issues with intravenous immunoglobulin (IVIg) therapy approval for patients with autoimmune gastrointestinal dysmotility (AGID) and the outcomes of missed IVIg treatments.
Output Formats

atom, dcmes-xml, json, omeka-xml, rss2